Literature DB >> 16642532

Anticancer cyclometalated [Au(III)m(C(wedge)N(wedge)C)mL]n+ compounds: Synthesis and cytotoxic properties.

Carrie Ka-Lei Li1, Raymond Wai-Yin Sun, Steven Chi-Fai Kui, Nianyong Zhu, Chi-Ming Che.   

Abstract

A series of cyclometalated gold(III) compounds [Au(m)(C(wedge)N(wedge)C)mL]n+ (m = 1-3; n = 0-3; HC(wedge)N(wedge)CH = 2,6-diphenylpyridine) was prepared by ligand substitution reaction of L with N-donor or phosphine ligands. The [Au(m)(C(wedge)N(wedge)C)mL]n+ compounds are stable in solution in the presence of glutathione. Crystal structures of the gold(III) compounds containing bridging bi- and tridentate phosphino ligands reveal the presence of weak intramolecular pi pi stacking between the [Au(C(wedge)N(wedge)C)]+ units. Results of MTT assays demonstrated that the [Au(m)(C(wedge)N(wedge)C)mL]n+ compounds containing nontoxic N-donor auxiliary ligands (2) exert anticancer potency comparable to that of cisplatin, with IC50 values ranging from 1.5 to 84 microM. The use of [Au(C(wedge)N(wedge)C)(1-methylimidazole)]+ (2 a) as a model compound revealed that the gold(III)-induced cytotoxicity occurs through an apoptotic cell-death pathway. The cell-free interaction of 2 a with double-stranded DNA was also examined. Absorption titration showed that 2 a binds to calf-thymus DNA (ctDNA) with a binding constant of 4.5 x 10(5) dm3 mol(-1) at 298 K. Evidence from gel-mobility-shift assays and viscosity measurements supports an intercalating binding mode for the 2 a-DNA interaction. Cell-cycle analysis revealed that 2 a causes S-phase cell arrest after incubation for 24 and 48 hours. The cytotoxicity of 3 b-g toward cancer cells (IC50 = 0.04-4.3 microM) correlates to that of the metal-free phosphine ligands (IC50 = 0.1-38.0 microM), with [Au2(C(wedge)N(wedge)C)2(mu-dppp)]2+ (3 d) and dppp (dppp = 1,2-bis(diphenylphosphino)propane) being the most cytotoxic gold(III) and metal-free compounds, respectively. Compound 3 d shows a cytotoxicity at least ten-fold higher than the other gold(III) analogues; in vitro cellular-uptake experiments reveal similar absorptions for all the gold(III) compounds into nasopharyngeal carcinoma cells (SUNE1) (1.18-3.81 ng/cell; c.f., 3 d = 2.04 ng/cell), suggesting the presence of non-gold-mediated cytotoxicity. Unlike 2 a, both gold(III) compounds [Au(C(wedge)N(wedge)C)(PPh3)]+ (3 a) (PPh3 = triphenylphosphine) and [Au2(C(wedge)N(wedge)C)2(mu-dppp)]2+ (3 d) interact only weakly with ctDNA and do not arrest the cell cycle.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16642532     DOI: 10.1002/chem.200600117

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  10 in total

1.  Synthesis of apoptosis-inducing iminophosphorane organogold(III) complexes and study of their interactions with biomolecular targets.

Authors:  Neha Shaik; Alberto Martínez; Idline Augustin; Hugh Giovinazzo; Armando Varela-Ramírez; Mercedes Sanaú; Renato J Aguilera; María Contel
Journal:  Inorg Chem       Date:  2009-02-16       Impact factor: 5.165

Review 2.  Current applications and future potential for bioinorganic chemistry in the development of anticancer drugs.

Authors:  Sabine H van Rijt; Peter J Sadler
Journal:  Drug Discov Today       Date:  2009-09-24       Impact factor: 7.851

3.  Reactivity of the [Au(C^N^C)Cl] complex in the presence of H2O and N-, S- and Se-containing nucleophiles: a DFT study.

Authors:  G Y Sánchez Delgado; D Paschoal; H F Dos Santos
Journal:  J Biol Inorg Chem       Date:  2018-09-12       Impact factor: 3.358

4.  (μ-Diphenyl-phosphanido-κP:P')bis-[2,2'-(pyridine-2,6-diyl)diphenyl-κC,N,C)gold(III)] perchlorate acetonitrile solvate.

Authors:  Xin-Sheng Li; Juan Mo; Su-Mei Zhang; Li Yuan; Jian-Hua Liu
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-08-06

5.  Cyclometalated Iminophosphorane Gold(III) and Platinum(II) Complexes. A Highly Permeable Cationic Platinum(II) Compound with Promising Anticancer Properties.

Authors:  Malgorzata Frik; Jacob Fernández-Gallardo; Oscar Gonzalo; Víctor Mangas-Sanjuan; Marta González-Alvarez; Alfonso Serrano del Valle; Chunhua Hu; Isabel González-Alvarez; Marival Bermejo; Isabel Marzo; María Contel
Journal:  J Med Chem       Date:  2015-07-22       Impact factor: 7.446

6.  4,6-Dihydroxysalicylic Acid-Catalyzed Oxidative Condensation of Benzylic Amines and Aromatic Ketones for the Preparation of 2,4,6-Trisubstituted Pyridines and Its Application to Metal-Free Synthesis of G-Quadruplex Binding Ligands.

Authors:  Chun-Ping Dong; Shintaro Kodama; Akihiro Nomoto; Michio Ueshima; Akiya Ogawa
Journal:  ACS Omega       Date:  2019-05-23

7.  Gold(I/III)-Phosphine Complexes as Potent Antiproliferative Agents.

Authors:  Jong Hyun Kim; Evan Reeder; Sean Parkin; Samuel G Awuah
Journal:  Sci Rep       Date:  2019-08-26       Impact factor: 4.379

Review 8.  Gold-Based Medicine: A Paradigm Shift in Anti-Cancer Therapy?

Authors:  Chien Ing Yeo; Kah Kooi Ooi; Edward R T Tiekink
Journal:  Molecules       Date:  2018-06-11       Impact factor: 4.411

9.  Osmium Arene Germyl, Stannyl, Germanate, and Stannate Complexes as Anticancer Agents.

Authors:  Tomiris Nabiyeva; Basile Roufosse; Matylda Odachowski; Judith Baumgartner; Christoph Marschner; Akalesh Kumar Verma; Burgert Blom
Journal:  ACS Omega       Date:  2021-07-12

Review 10.  Computational Studies of Au(I) and Au(III) Anticancer MetalLodrugs: A Survey.

Authors:  Iogann Tolbatov; Alessandro Marrone; Cecilia Coletti; Nazzareno Re
Journal:  Molecules       Date:  2021-12-15       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.